Going Cercern	3 Months Ended
Sep. 30, 2025
Going Cercern [Abstract]
GOING CERCERN	NOTE 3 – GOING CERCERN The Company’s financial statements are prepared assuming that the Company will continue as a going concern. The Company had negative operating cash flows during the reporting period from July 1, 2025 through September 30, 2025. In addition, as more fully described in Note 17, Subsequent Events, on October 13, 2025, the Company was notified by NYSE of its determination to commence proceedings to delist the Company’s common stock. The Company has a right to a review of this determination by a Committee of the Board of Directors of the NYSE. However, the Company does not intend to appeal the NYSE’s determination. Accordingly, the NYSE filed a Form 25 with the SEC on October 27, 2025, to remove the Company’s common stock from listing and registration on the NYSE. The delisting became effective 10 days after the filing of the Form 25. Following the delisting, the Company’s common stock is expected to be quoted on the OTC Markets Group Inc. under the symbol “ENFY”. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of at least one year from the date these financial statements are issued. The ability of the Company to continue as a going concern is dependent upon its ability to secure alternative sources of financing and ultimately achieve profitable operations. The delisting, if finalized, will severely impair our ability to raise capital through public equity markets. Management’s plans to mitigate these adverse conditions include implementing cost-reduction measures, and exploring alternative financing arrangements. However, there can be no assurance that the Company’s plans will be successful. The accompanying financial statements do not include any adjustments to reflect the carrying values and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.

Going Cercern

3 Months Ended

Sep. 30, 2025

NOTE 3 – GOING CERCERN

The Company’s financial statements are prepared assuming that the Company will continue as a going concern. The Company had negative operating cash flows during the reporting period from July 1, 2025 through September 30, 2025. In addition, as more fully described in Note 17, Subsequent Events, on October 13, 2025, the Company was notified by NYSE of its determination to commence proceedings to delist the Company’s common stock. The Company has a right to a review of this determination by a Committee of the Board of Directors of the NYSE. However, the Company does not intend to appeal the NYSE’s determination. Accordingly, the NYSE filed a Form 25 with the SEC on October 27, 2025, to remove the Company’s common stock from listing and registration on the NYSE. The delisting became effective 10 days after the filing of the Form 25. Following the delisting, the Company’s common stock is expected to be quoted on the OTC Markets Group Inc. under the symbol “ENFY”. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of at least one year from the date these financial statements are issued.

The ability of the Company to continue as a going concern is dependent upon its ability to secure alternative sources of financing and ultimately achieve profitable operations. The delisting, if finalized, will severely impair our ability to raise capital through public equity markets.

Management’s plans to mitigate these adverse conditions include implementing cost-reduction measures, and exploring alternative financing arrangements. However, there can be no assurance that the Company’s plans will be successful.

The accompanying financial statements do not include any adjustments to reflect the carrying values and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.